Epivax, Inc.

Biotechnology company · Providence, Rhode Island, United States

Epivax, Inc. is a biotechnology company headquartered in Providence, Rhode Island, United States. It has received 16 US government small-business research awards (SBIR/STTR) from health agencies, $8.5 million in total, most recently in 2023.

www.epivax.comProfile compiled from public records. Is this your company? Request a correction or update

Epivax at a glance

Typebiotechnology company
HeadquartersProvidence, Rhode Island, United States
Employees (self-reported, 2023)28

What does Epivax do?

US government research funding

16 SBIR/STTR small-business research awards from US health agencies, $8.5 million in total (1999 to 2023). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences.

Frequently asked questions about Epivax

Where is Epivax headquartered?

Epivax, Inc. is headquartered in Providence, Rhode Island, United States.

What does Epivax do?

Epivax, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences